Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Autor: Luszczak, Sabina1, Simpson, Benjamin S.1, Stopka-Farooqui, Urszula1, Sathyadevan, Vignesh Krishna1, Echeverria, Lina M. Carmona1, Kumar, Christopher1, Costa, Helena2, Haider, Aiman2, Freeman, Alex2, Jameson, Charles2, Ratynska, Marzena2, Ben-Salha, Imen2, Sridhar, Ashwin3, Shaw, Greg3, Kelly, John D.3, Pye, Hayley1, Gately, Kathy A.4, Whitaker, Hayley C.1, Heavey, Susan1 s.heavey@ucl.ac.uk
Zdroj: Scientific Reports. 9/1/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje